Concepedia
Statistics
Publications
13
Citations
834
H-Index
12
Active since
2004
Affiliations
Eli Lilly (United States)(Current)
Huazhong Agricultural University
Center of Hubei Cooperative Innovation for Emissions Trading System
Constellation Pharmaceuticals (United States)
Zhixiang Yang is an author at Eli Lilly (United States) specializing in life sciences, pharmacology, and enzyme inhibition.
Publications per year
2004–2024
γ-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer’s Disease
Lutgarde Serneels, Jérôme Van Biervliet, Katleen Craessaerts et al. · Science · 2009 · 260 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +14
The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans
Patrick C. May, Brian A. Willis, Stephen L. Lowe et al. · Journal of Neuroscience · 2015 · 205 citations · Full text
Life Sciences, Medicinal Chemistry, Pharmacology +17
Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma
Zhixiang Yang, Dong Wang, Ge Wang et al. · Journal of Cancer Research and Clinical Oncology · 2009 · 85 citations · Full text
Medicine, Oncology, Radiation Oncology +16
Identification of novel proteolytically inactive mutations in coronavirus 3C‐like protease using a combined approach
Liurong Fang, Zhixiang Yang, Shangen Xu et al. · The FASEB Journal · 2019 · 61 citations
Life Sciences, Biochemistry, Molecular Biology +17
O3-06-07 Multi-compartmental pharmacodynamic assessment of the functional gamma-secretase inhibitor LY450139 in PDAPP transgenic mice and non-transgenic mice
Patrick C. May, Zhixiang Yang, Weiying Li et al. · Neurobiology of Aging · 2004 · 39 citations
Medicine, Pharmacokinetics, Pharmacology +14
1–5 of 13